DMAA Drugs Made In America Acquisition Corp. - Ordinary Shares
$10,72
Harga · Agu 18, 2026
Fundamental per Apr 15, 2026
Rentang 52M
$10–$11
100% of range
Peringkat Analis
—
Target Harga
—
P/E (TTM)
—
ROE
-82.4%
Margin Laba Bersih
—
DMAA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$10.72
Kapitalisasi Pasar
$115M
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-82.4%
D/E Utang/Ekuitas
—
Rentang 52M
$10 – $11
DMAA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
DMAA
Median Rekan
P/B
-15.8
0.9
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
DMAA
Median Rekan
ROA
4.9%
3.1%
ROE
-82.4%
3.9%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Current Ratio (Rasio Lancar)
0.0
1.8
Quick Ratio (Rasio Cepat)
0.0
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 6
| Metrik | Tren | 2025 |
|---|---|---|
| SG&A Expense | $3M | |
| Operating Income | $-3M | |
| Interest Income | $9M | |
| Other Non-op | $9M | |
| Net Income | $6M | |
| EBITDA | $-3M |
Neraca 12
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $6.1K | |
| Prepaid Expense | $6.1K | |
| Current Assets | $12.2K | |
| Total Assets | $240M | |
| Accounts Payable | $222.2K | |
| Current Liabilities | $376.2K | |
| Total Liabilities | $7M | |
| Common Stock | $1.1K | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $240M | |
| Shares Outstanding | 10,717,143 |
Arus Kas 3
| Metrik | Tren | 2025 |
|---|---|---|
| Operating Cash Flow | $-539.2K | |
| Investing Cash Flow | $-231M | |
| Financing Cash Flow | $232M |
Profitabilitas 2
| Metrik | Tren | 2025 |
|---|---|---|
| ROA | 4.9% | |
| ROE | -82.4% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 |
|---|---|---|
| Current Ratio | 0.0 | |
| Quick Ratio | 0.0 |
Valuasi (TTM) 4
| Metrik | Tren | 2025 |
|---|---|---|
| Net Income TTM | $6M | |
| Market Cap | $111M | |
| P/B | -15.3 | |
| P / Cash Flow | -206.2 |
Laporan Laba Rugi 6
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| SG&A Expense | $2M | $263.7K | $131.9K | $330.9K | |
| Operating Income | $-2M | $-263.7K | $-131.9K | $-330.9K | |
| Interest Income | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | · | |
| Net Income | $213.0K | $2M | $2M | $1M | |
| EBITDA | · | $-263.7K | $-131.9K | $-330.9K |
Neraca 13
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6.1K | $717 | $822 | $923 | |
| Prepaid Expense | $6.1K | $27.5K | $48.9K | $70.1K | |
| Current Assets | $12.2K | $28.2K | $49.7K | $71.0K | |
| Total Assets | $240M | $238M | $235M | $233M | |
| Accounts Payable | $222.2K | · | · | · | |
| Accrued Liabilities | · | $302.6K | $147.5K | $132.5K | |
| Current Liabilities | $376.2K | $456.6K | $301.4K | $347.4K | |
| Total Liabilities | $7M | $7M | $7M | $7M | |
| Common Stock | $1.1K | $1.1K | $1.1K | $1.1K | |
| Retained Earnings | $-7M | $-7M | $-6M | $-6M | |
| Stockholders' Equity | $-7M | $-7M | $-7M | $-7M | |
| Liabilities + Equity | $240M | $238M | $235M | $233M | |
| Shares Outstanding | 10,717,143 | 10,517,143 | 10,517,143 | 10,517,143 |
Arus Kas 3
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-125.2K | $-56.1K | $-106.7K | $-251.2K | |
| Investing Cash Flow | $0 | $0 | $0 | $-231M | |
| Financing Cash Flow | $130.6K | $56.0K | $106.6K | $231M |
Profitabilitas 2
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| ROA | · | 1.8% | 1.9% | 1.1% | |
| ROE | · | -59.6% | -64.0% | -35.0% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | · | 0.1 | 0.2 | 0.2 | |
| Quick Ratio | · | 0.0 | 0.0 | 0.0 |
Valuasi (TTM) 4
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Net Income TTM | · | $6M | · | · | |
| Market Cap | · | $108M | $107M | $105M | |
| P/B | · | -14.7 | -15.0 | -14.7 | |
| P / Cash Flow | · | · | · | -419.4 |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Laba Bersih | $6M | — |
Neraca
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Rasio Lancar | 0.0 | — |
| Rasio Cepat | 0.0 | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 25 pengaju · $122.7M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 1 (-4 vs Kuartal sebelumnya) | 17 (+11 vs Kuartal sebelumnya) | 3 (-4 vs Kuartal sebelumnya) | 14 (+7 vs Kuartal sebelumnya) | -10.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Karpus Management, Inc. | $26.708.251 | 2.507.817 | 21,77% | Saham |
| MIZUHO SECURITIES USA LLC | $21.930.113 | 2.069.605 | 17,87% | Saham |
| Polar Asset Management Partners Inc. | $12.204.900 | 1.146.000 | 9,95% | Saham |
| WOLVERINE ASSET MANAGEMENT LLC | $8.861.790 | 832.093 | 7,22% | Saham |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $8.616.425 | 809.054 | 7,02% | Saham |
| First Trust Capital Management L.P. | $8.375.788 | 786.459 | 6,83% | Saham |
| HEIGHTS CAPITAL MANAGEMENT, INC | $6.902.084 | 648.083 | 5,62% | Saham |
| Westchester Capital Management, LLC | $6.086.613 | 571.513 | 4,96% | Saham |
| MIZUHO SECURITIES USA LLC | $5.402.472 | 542.962 | 4,40% | Saham |
| ATW SPAC MANAGEMENT LLC | $5.135.000 | 500.000 | 4,18% | Saham |
| ARISTEIA CAPITAL, L.L.C. | $3.727.500 | 350.000 | 3,04% | Saham |
| Clear Street Group Inc. | $1.645.529 | 382.440 | 1,34% | Saham |
| Logan Stone Capital, LLC | $1.171.063 | 109.959 | 0,95% | Saham |
| CLEAR STREET LLC | $1.148.673 | 112.615 | 0,94% | Saham |
| TORONTO DOMINION BANK | $1.065.000 | 100.000 | 0,87% | Saham |
| Meteora Capital, LLC | $1.041.964 | 97.837 | 0,85% | Saham |
| Quarry LP | $698.118 | 65.551 | 0,57% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $663.207 | 62.273 | 0,54% | Saham |
| JPMORGAN CHASE & CO | $531.339 | 49.891 | 0,43% | Saham |
| Dakota Wealth Management | $387.660 | 36.400 | 0,32% | Saham |
| Lineage Point Capital LP | $339.096 | 31.840 | 0,28% | Saham |
| SONA ASSET MANAGEMENT (US) LLC | $52.015 | 4.884 | 0,04% | Saham |
| GLAZER CAPITAL, LLC | $10.649 | 999.899 | 0,01% | Saham |
| MORGAN STANLEY | $298 | 28 | 0,00% | Saham |
| HRT FINANCIAL LP | $196 | 18.483 | 0,00% | Saham |
Orang dalam perusahaan 6 orang dalam · 2 pejabat · 4 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | 18 Feb. 2025 P | 4.188.780 | 0 | 0 | $0 |
| Glenn C. Worman | CFO | 29 Jan. 2025 J | 100.000 | 0 | 0 | $0 |
| Catherine Do | Direktur | 29 Jan. 2025 J | 100.000 | 0 | 0 | $0 |
| Myron W. Shulgan | Direktur | 29 Jan. 2025 J | 100.000 | 0 | 0 | $0 |
| Sridhar G. Prasad | Direktur | 29 Jan. 2025 J | 100.000 | 0 | 0 | $0 |
| Drugs Made In America Acquisition LLC | Pemilik 10% | 18 Feb. 2025 P | 4.188.780 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC, Lynn Stockwell | 3 Maret 2025 | 12,50% | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.